Podtech
Derisk your vaccine production with flexible manufacturing capabilities
In May 2024, life sciences industry analysts at McKinsey & Company released an article about innovation in vaccines. Their study compared trends they witnessed in 2019 to trends prevalent five years later, post the unprecedented Covid-19 pandemic. Within less than a decade, the vaccine development, production and business landscape was fundamentally altered. In…
Read MorePreparing for future pandemic threats with PodTech™
In September 2024, the Abbott Pandemic Defense Coalition released the results of a survey of over 100 experts in epidemiology, virology and infectious diseases from around the world. This survey of experts addressed some of the most important questions of our post-Covid-19-pandemic times. How prepared are we to deal with another pandemic? What…
Read MoreGetting prefabricated pharma factory construction right: How to make an informed decision
In today’s world, the biopharma industry faces unique challenges, driven by climate change, a growing global population, and humanitarian crises. This state of the world has resulted in a growing demand for vaccines, medicines, diagnostics and medical technologies. Combined with the complexities of unpredictable demand and inflexibility in production capacities, being a biopharmaceutical manufacturer is…
Read MoreExpanding access to tuberculosis care using PodTech™s modular facilities
Despite spectacular advances in biopharmaceutical research, drug development and overall quality of life over the past few decades, tuberculosis remains a stain on global health progress. 8.2 million people were newly diagnosed with tuberculosis (TB) in 2023. That number is not only a notable increase from the 7.5 million reported the year prior, but…
Read MoreEnabling climate resilience with PodTech™
Human health is inextricably linked with environmental health in more ways than you think. Beyond the direct health impacts of extreme weather events like floods and heatwaves, there are several indirect impacts that affect people’s health and overall quality of life. A World Economic Forum report titled Quantifying the Impact of Climate Change on…
Read MoreAll you need to know about off-site modular fabrication of biopharma manufacturing facilities
As the biopharma industry becomes more technologically advanced, it is also driving the demand for innovative solutions to optimise drug development costs. It is demanding improvements in the construction delivery process. And it is demanding that the trickle-down effects of these advances reach every person in the world. In other words, as the biopharma…
Read MoreModular cleanrooms to democratise biopharma development and healthcare access
Cleanrooms are classified enclosed spaces within which controlled environmental conditions are maintained to minimise the presence of airborne and other contaminants. Air handling and other environmental control systems are used to maintain the required temperature, pressure, humidity, air filtration, etc. Given the stringent demand for controlled hygienic environments while making drugs, vaccines and other health…
Read MoreWhat to look for in a prefab pharma factory solutions provider
Setting up a biopharmaceutical manufacturing facility is a significant investment. From acquiring land and building a structure that meets all regulatory standards to equipping it with the right machines, setting standard operating procedures, procuring inputs and training your staff, there’s no dearth of pressures on your time, effort and budget. Outsourcing an important part…
Read MoreWhy prefabricated pharmaceutical factories? The benefits of prefabrication over traditional construction for the biopharma sector
Making medicines, vaccines, diagnostics and other health products isn’t a concern for only the discipline of biochemistry. Developing, producing, distributing and consuming these products entails the coming together of multiple activities, sectors and industries – from basic scientific research to clinical trials, from governmental regulations to business environments, from health and advocacy to packaging and…
Read MoreConcept of scale: PodTech™ to aid quick scaling up of facilities and infrastructure
Since GLP-1 receptor agonist drugs came on the market to treat obesity and diabetes, their popularity has been unprecedented. As often happens in such situations, the massive demand for these treatments resulted in a chronic supply shortage – one that will persist until manufacturers’ investments in scaling production begin to bear fruit. So high…
Read More